Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug

[VUBot]

Intercept Pharmaceuticals said Friday it will restructure itself after the FDA rejected its liver disease treatment. ICPT stock sank. The post Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug appeared first on Investor's Business Daily.

#fda

Continue reading...